Kristin Hudock
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation (NCT04492514) | Kristin Hudock | 2020-05-20 |
Track Kristin Hudock automatically
Every clearance here is in the API, with alerts when new ones post.